Adaptive PTSD Interventions for PTSD
Trial Summary
The trial does not specify if you need to stop taking your current medications, but it does require that your psychotropic medication has been stable for at least 4 weeks before joining.
Prolonged Exposure (PE) therapy, a key component of the treatment, is shown to be effective in reducing PTSD symptoms, with studies indicating medium-to-large reductions in PTSD and small-to-medium reductions in depression symptoms. PE for Primary Care (PE-PC), a brief version of PE, has been effective in primary care settings, making it more accessible for patients.
12345Prolonged exposure therapy, including its version for primary care (PE-PC), is generally considered safe for treating PTSD, with studies showing it effectively reduces PTSD and depression symptoms. There is no specific mention of safety concerns in the research articles, suggesting it is well-tolerated by patients.
12356Prolonged Exposure for Primary Care (PE-PC) is a shorter, more accessible version of traditional prolonged exposure therapy, designed specifically for primary care settings. It involves four 30-minute sessions focusing on confronting trauma memories and related avoidance, making it more feasible for patients who prefer or have easier access to primary care rather than specialized mental health services.
12345Eligibility Criteria
This trial is for individuals with PTSD receiving care at certain Michigan health centers, who score ≥33 on the PTSD checklist and have stable psychotropic medication use for 4 weeks. They must own a mobile device compatible with the PTSD Coach App. Excluded are those currently in trauma-focused treatment, with severe cognitive impairment, non-English speakers, high suicide risk, active psychosis or unmanaged bipolar disorder, severe substance abuse issues, or unstable housing.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants receive either Clinician Supported PTSD Coach App or Prolonged Exposure for Primary Care (PE-PC) for four weekly sessions or up to 9 weeks
Adaptive Treatment
Based on response, participants either continue with the initial treatment or switch to a different therapy for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Full Prolonged Exposure is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)